SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 2.79 |
Enterprise Value ($M) | 10.59 |
Book Value ($M) | 4.80 |
Book Value / Share | 0.41 |
Price / Book | 0.58 |
NCAV ($M) | 4.26 |
NCAV / Share | 0.37 |
Price / NCAV | 0.66 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.76 |
Return on Assets (ROA) | -0.50 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.39 |
Current Ratio | 2.55 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 7.24 |
Assets | 7.78 |
Liabilities | 2.99 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.25 |
Operating Income | -5.15 |
Net Income | -3.77 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -4.54 |
Cash from Investing | -0.12 |
Cash from Financing | 6.47 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Knight Therapeutics (Barbados) Inc. | 19.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
141,609 | 770,171 | 18.39 | |
1,925 | 34,797 | 5.53 | |
7,865 | 18,379 | 42.79 | |
3,419 | 4,734 | 72.22 | |
(click for more detail) |
Similar Companies | |
---|---|
SPRC – SciSparc Ltd. | SRZN – Surrozen, Inc. |
SXTC – China SXT Pharmaceuticals, Inc. | SYBX – Synlogic, Inc. |
TCON – TRACON Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io